DiaCarta to go Public Through SPAC Merger
The firm would join a number of biopharma and diagnostic companies that have used SPACs during the COVID-19 pandemic to tap the public markets.
Source: 360dx.com
Stay updated with breaking news from Carta Founder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The firm would join a number of biopharma and diagnostic companies that have used SPACs during the COVID-19 pandemic to tap the public markets.
Growing up, Kevin Song witnessed his Korean immigrant parents build and grow a grocery store business in Brooklyn, New York. To the family, he recalls, the business was more about making a living. It was about being an integral part of the surrounding community – from sponsoring Little League games to serving as ambassadors for […]